New York Eye Specialists Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04403516
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Michelle Rhee MD | New York Eye Specialists